Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Bioorg Med Chem. 2015 Jul 26;23(17):5483–5488. doi: 10.1016/j.bmc.2015.07.034

Table 1. Potencies of ULK1 inhibitors.

Compounds were tested against ULK1, ULK2 and PDK1 in an in vitro kinase assay. Assay was performed in duplicate.

Compound Structure ULK1 IC50 (nM) ULK2 IC50 (nM) PDK1 IC50 (nM)
Compound 1 graphic file with name nihms-715401-t0004.jpg 5.3 ± 0.91 13 ± 3.3 420 ± 43
BX-795 graphic file with name nihms-715401-t0005.jpg 87 ± 7.4 310 ± 88 65 ± 3.9
Compound 2 graphic file with name nihms-715401-t0006.jpg 67 ± 15 200 ± 49 56 ± 5.5
Compound 3 graphic file with name nihms-715401-t0007.jpg 120 ± 1.7 360 ± 79 710 ± 270
MRT67307 graphic file with name nihms-715401-t0008.jpg 170 ± 11 230 ± 21 421±19